NCT Number: NCT00200122
Restore Claims Characterization Study
The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Contact Medtronic for Exact Location, Chicago, Illinois, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Has chronic refractory pain associated with one of the conditions currently approved for spinal cord stimulation as follows: Failed Back Syndrome, Degenerative Disk Disease (DDD), Herniated Disk pain refractory to conservative and surgical interventions, Peripheral Causalgia, Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy (RSD).
- Primary pain in the lower half of the body.
Exclusion criteria
- Requires, or will in the future, diathermy treatments.
- Had implanted spinal cord stimulation system within the last six months.
Treatment and study plan
Primary outcomes
-
The primary endpoint is to assesses the pain coverage capability of the RESTORE SCS system.
Secondary outcomes
-
Secondary outcome measures include pain relief, quality of life, function, patient and physician acceptance.
Sponsors and collaborators
Lead sponsor
MedtronicNeuro
Industry
Registry information
Important dates
- Study start
- 2005
- Study completion
- 2007
- First posted
- Sep 20, 2005
- Registry last updated
- Jan 21, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Empowered Relief for Youth
NCT05998369
Abdominal Pain, Autonomic Nervous System Diseases
Palo Alto, California, United States
View Trial DetailsInterest of Day Hospital Care for Patients With Chronic Regional Pain Syndrome Referred to the Chronic Pain Unit for the First Time
NCT04913051
Autonomic Nervous System Diseases, Chronic Regional Pain Syndrome
Le Mans, France
View Trial DetailsRole of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery
NCT02390505
Autonomic Nervous System Diseases, Complex Regional Pain Syndrome (CRPS) TYPE I
Amiens, France
View Trial DetailsEvaluation of the Relationship Between the Duration of the Evolution of the Complex Regional Pain Syndrome Type 1 (CRPS 1) and Effectiveness of the Continuous Peripheral Nerve Block (CPNB) Associated With an Intensive Rehabilitation Program
NCT04767646
Autonomic Nervous System Diseases, CRPS (Complex Regional Pain Syndrome) Type I
Rennes, Brittany Region, France
View Trial Details